Urothelial Carcinoma Highlights from ASCO GU 2021: Ground-Breaking Studies

Urothelial Carcinoma Highlights from ASCO GU 2021: Ground-Breaking Studies

Bibliographic Details
Main Author:	Frank Stenner
Format:	Article
Language:	English
Published:	THE HEALTHBOOK COMPANY LTD. 2021-06-01
Series:	healthbook TIMES. Oncology Hematology
Online Access:	https://healthbook-times.scholasticahq.com/article/27177-urothelial-carcinoma-highlights-from-asco-gu-2021-ground-breaking-studies.pdf

Similar Items

The Changing Landscape of Urothelial Carcinoma Therapy: Updates from ASCO GU 2023
by: Alex Friedlaender
Published: (2023-06-01)

Novel ADCs and combination therapy in urothelial carcinoma: latest updates from the 2023 ASCO-GU Cancers Symposium
by: Jiazheng Yu, et al.
Published: (2023-07-01)

New treatments and trials for renal cell carcinoma: Latest updates from 2023 ASCO-GU Cancers Symposium
by: Yiqing Guo, et al.
Published: (2023-11-01)

Genitourinary cancers updates: highlights from ASCO 2023
by: Qian Qin, et al.
Published: (2023-11-01)

Novel agents and clinical trials in castration-resistant prostate cancer: latest updates from 2023 ASCO-GU Cancers Symposium
by: Yuanhong Jiang, et al.
Published: (2023-08-01)

New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting
by: Matthieu Roulleaux-Dugage, et al.
Published: (2023-08-01)

Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
by: Minghan Qiu, et al.
Published: (2022-08-01)

Repetition and distance in ASCO’s fotonovelas
by: Paloma Checa Gismero
Published: (2016-10-01)

Aktivnosti največjega mednarodnega strokovnega združenja onkologov ASCO in pogled na srečanje ASCO 2011
by: Tanja Čufer
Published: (2011-12-01)

An Interpretation of CSCO/ASCO International Guideline of Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage Ⅱ-Ⅳa Nasopharyngeal Carcinoma in 2021
by: ZHOU Yajuan, et al.
Published: (2021-05-01)

Urothelial Carcinoma in an Allograft kidney
by: Maria Baand Hejlesen, et al.
Published: (2022-05-01)

Response to Gu et al’s “Treatment-resistant dermatophytosis: A representative case highlighting an emerging public health threat”
by: Manar T. Edriss, BS, et al.
Published: (2023-02-01)

Zhang guo gu dai shi xue wan yan gu shi song /
by: 566562 Yan, Bei Min
Published: (1980)

The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS
by: Hyerim Ha, et al.
Published: (2022-07-01)

Improving the accumulation of 18α-and 18β-glycyrrhizins by over-expressing GuHMGR, GuSQS1, and GuBAS genes in Glycyrrhiza uralensis
by: Rui Yang, et al.
Published: (2017-10-01)

Changshin-gu : personal ornaments
Published: (1995)

Global Equity in Clinical Trials: An ASCO Policy Statement
by: Sana A. Al Sukhun, et al.
Published: (2024-03-01)

ASCO 2023: Targeted Therapy for Early-Stage NSCLC
by: Roy Herbst
Published: (2023-06-01)

ASCO 2023: Recent Progress in Lung Cancer Therapy
by: Charu Aggarwal
Published: (2023-06-01)

Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
by: Olga Bodriagova, et al.
Published: (2023-09-01)

Interpretation on Management of Dyspnea in Advanced Cancer: ASCO Guideline
by: JIA Zhimeng, et al.
Published: (2024-01-01)

Sarcomatoid urothelial carcinoma
by: Orelvys González Otaño, et al.
Published: (2012-04-01)

The “GU-GU-RU” project to eliminate discrimination related to the health effects of the Fukushima nuclear accident
by: Isamu Amir, et al.
Published: (2023-10-01)

First Brazilian consensus on the management of localized and locally advanced urothelial bladder cancer: a SBU-SBOC-SBRT-LACOG-GU panel review
by: Lucas Nogueira, et al.
Published: (2021-10-01)

Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023
by: Hong Zheng, et al.
Published: (2023-02-01)

Breaking Age Barriers: The Benefits of CAR T-Cell Therapies in Treating Large B-Cell Lymphoma in Older Patients
by: Frank Stenner, et al.
Published: (2023-12-01)

International Collaboration on Palliative Care Development Between ASCO and the Land of Hornbills
by: Yin Yee Wong, et al.
Published: (2023-06-01)

Dearly cherish the memory of Academician Gu Gongxu：In commemoration of the 30th anniversary of Prof. Gu’s death
by: Chunyan Xiao
Published: (2022-01-01)

Melancolía, asco y lenguaje corporal en la anorexia
by: Elvia Mireya Ahedo Rodríguez
Published: (2010-01-01)

Repetición y distancia en las fotonovelas de ASCO
by: Paloma Checa Gismero
Published: (2016-10-01)

Electrochemical oxidation of the phospha‐ and arsaethynolate anions, PCO– and AsCO–
by: Tambornino, F, et al.
Published: (2019)

El asco: una emoción entre naturaleza y cultura
by: Eduardo Alberto León
Published: (2013-11-01)

UMP, GU meterai MoU
by: UMP, LIB
Published: (2016)

Dėl priesagos -gu- pirminės reikšmės
by: R. Mironas
Published: (1961-12-01)

Dėl priesagos -gu- pirminės reikšmės
by: R. Mironas
Published: (1961-12-01)

Cutaneous metastasis of urothelial carcinoma
by: Alexandra Baczynski, et al.
Published: (2024-01-01)

Micropapillary Variant of Urothelial Carcinoma
by: Ghee Young Kwon, et al.
Published: (2011-01-01)

Clinicopathological features of urothelial carcinoma
by: ZHOU Xiaodie, CHEN Weiwei, YU Bo, WANG Xuan, WANG Jianjun, SHI Qunli, RAO Qiu, BAO Wei
Published: (2023-06-01)

Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO
by: Maria T. Bourlon, et al.
Published: (2024-04-01)

Advancing Ovarian Cancer Treatment: The Latest Insights on PARP Inhibitors from ASCO 2023
by: Yves van Roon, et al.
Published: (2023-12-01)